Innovations in regenerative medicine and stem cell therapy for diabetes offer hope for restoring insulin production and reversing disease progression. Stem cell-derived beta-cell transplants are being developed to replace damaged pancreatic cells, providing a potential cure for type 1 diabetes. Advances in tissue engineering and gene editing technologies, such as CRISPR, enable the creation of personalized regenerative therapies. Encapsulation techniques protect transplanted cells from immune attack, enhancing long-term viability. While challenges remain in achieving sustained insulin secretion and immune tolerance, ongoing clinical trials are bringing regenerative medicine closer to clinical application. These breakthroughs could revolutionize diabetes treatment, reducing dependence on insulin therapy
Yong Xiao Wang
Albany Medical Center, United States
F Buck Willis
Belize Bible College, Belize
Gretchen Holmes
Memorial Hospital at Gulfport, United States
Sujith Rajan
NYU Long Island School of Medicine, United States
Amy Gutman
AdventHealth; Tough Love MD, United States
Paraskevi Theofilou
Hellenic Open University, Greece
Teji S Dhami
Boost your Health and Wellness, United StatesSubmit your abstract Today
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, Belize Bible College, Belize
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Glucagon a plausible contributor, hiding in plain sight
Harris Edward Phillip, NHS, United Kingdom
Title : Clinical applications of monitoring unmethylated insulin cfDNA associated with beta-cell death for diabetes and metabolic diseases
Clifford Morris, Kihealth, United States